11,012
Views
46
CrossRef citations to date
0
Altmetric
Special Report

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 659-666 | Received 29 May 2020, Accepted 03 Jul 2020, Published online: 11 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paulo Roberto Bignardi, Carolina Santos Vengrus, Bruno Matos Aquino & Alcindo Cerci Neto. (2021) Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials. Pathogens and Global Health 115:3, pages 139-150.
Read now
Anna Bershteyn, Mark D. Schwartz, Lorna E. Thorpe, Michael K. Paasche-Orlow, Patricia Kissinger, Helen C. Stankiewicz Karita, Miriam K. Laufer, Risa M. Hoffman, Raphael J. Landovitz, Kristopher Paolino & Ruanne V. Barnabas. (2021) Taking a stand against the politicization of medical research: how ‘swinging the pendulum’ poses a hazard to clinical trials, study participants, and the progress of science. Expert Review of Clinical Immunology 17:1, pages 101-103.
Read now
Sebastian E. Sattui, Elizabeth R. Graef, Jean W. Liew, Jeffrey A. Sparks & Alfred H.J Kim. (2021) Reply to ‘Taking a stand against the politicization of medical research: how “swinging the pendulum” poses a hazard to clinical trials, study participants, and the progress of science’. Expert Review of Clinical Immunology 17:1, pages 105-107.
Read now

Articles from other publishers (43)

Sarah Goglin & Jason Kolfenbach. (2023) The Impact of COVID ‐19 on Education and Training in Rheumatology: A Narrative Review . Arthritis Care & Research.
Crossref
Anna Montgomery, Gary Tarasovsky, Zara Izadi, Stephen Shiboski, Mary A Whooley, Jo Dana, Iziegbe Ehiorobo, Jennifer Barton, Lori Bennett, Lorinda Chung, Kimberly Reiter, Elizabeth Wahl, Meera Subash & Gabriela Schmajuk. (2023) An Electronic Dashboard to Improve Dosing of Hydroxychloroquine Within the Veterans Health Care System: Time Series Analysis. JMIR Medical Informatics 11, pages e44455.
Crossref
Durga Prasanna Misra & Vinod Ravindran. (2023) Rheumatology research in the post-COVID era—challenges and solutions. Rheumatology 62:2, pages 489-491.
Crossref
Ariella Coler-Reilly, Elizabeth R. Graef, Alfred H.J. Kim, Jean W. Liew, Michael S. Putman, Sebastian E. Sattui, Kristen J. Young & Jeffrey A. Sparks. (2022) Social media for research discourse, dissemination, and collaboration in rheumatology. Rheumatology and Immunology Research 3:4, pages 169-179.
Crossref
Mervat S. Hassan, Dalia I. Mostafa, Enas I. Abdelhady, Shymaa A. Sarhan, Mohamed Abdelghani & Dina A. Seleem. (2022) Psychosocial and clinical impact of COVID-19 pandemic and its relationship to the quality of life in patients with rheumatoid arthritis: a cross-sectional study, Egypt. Middle East Current Psychiatry 29:1.
Crossref
Lauren J. Van Scoy, Sarah H. Duda, Allison M. Scott, Arian Baker, Heather Costigan, Morgan Loeffler, Michael S. Sherman & Michael D. Brown. (2022) A mixed methods study exploring requests for unproven COVID therapies such as ivermectin and healthcare distrust in the rural South. Preventive Medicine Reports, pages 102104.
Crossref
Émilien Schultz, Laëtitia Atlani-Duault, Patrick Peretti-Watel & Jeremy K. Ward. (2022) Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021. Therapies 77:5, pages 591-602.
Crossref
Mithu Maheswaranathan, Philip Chu, Andrew Johannemann, Lisa Criscione-Schreiber, Megan Clowse & David L. Leverenz. (2022) The Impact of the COVID-19 Pandemic and Telemedicine Implementation on Practice Patterns and Electronic Health Record Utilization in an Academic Rheumatology Practice. JCR: Journal of Clinical Rheumatology 28:2, pages e612-e615.
Crossref
Antoine Bosquet, Comlan Affo, Ludovic Plaisance, Géraldine Poenou, Emmanuel Mortier & Isabelle Mahé. (2022) Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists. PLOS ONE 17:1, pages e0261843.
Crossref
Tina Sikka. 2022. The Necessity of Critique. The Necessity of Critique 65 87 .
Arash Mollaeian, Daniel S. Kim & Christopher J. Haas. (2021) COVID-19 Prevalence and Outcomes among Individuals with Rheumatoid Arthritis and Systemic Lupus Erythematosus Taking Hydroxychloroquine; A Retrospective Analysis. The Open Rheumatology Journal 15:1, pages 69-76.
Crossref
Jessica González-Rangel, Brenda Pérez-Muñoz, Daniela Casillas-Santos, Ana Barrera-Vargas, Paola Vázquez-Cardenas, Ricardo Escamilla-Santiago & Javier Merayo-Chalico. (2021) Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America. Lupus 30:12, pages 1879-1887.
Crossref
Samar Tharwat, Sherin Zohdy Mohamed & Mohammed Kamal Nassar. (2021) Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic. Rheumatology 59:4, pages 237-243.
Crossref
Marcus J. C. Long & Yimon Aye. (2021) Science's Response to CoVID‐19. ChemMedChem 16:15, pages 2288-2314.
Crossref
Maya Aboumrad, Brian Shiner, Natalie Riblet, Hugh Huizenga, Nabin Neupane & Yinong Young-Xu. (2021) Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study. PLOS ONE 16:7, pages e0246217.
Crossref
Theodore L. Caputi. (2021) What cannabis can learn from Covid: Hydroxychloroquine research suggests the next step for medical cannabis research. International Journal of Drug Policy 93, pages 103133.
Crossref
Lonni Besançon, Nathan Peiffer-Smadja, Corentin Segalas, Haiting Jiang, Paola Masuzzo, Cooper Smout, Eric Billy, Maxime Deforet & Clémence Leyrat. (2021) Open science saves lives: lessons from the COVID-19 pandemic. BMC Medical Research Methodology 21:1.
Crossref
Lucie Perillat & Brian S. Baigrie. (2021) COVID ‐19 and the generation of novel scientific knowledge: Research questions and study designs . Journal of Evaluation in Clinical Practice 27:3, pages 694-707.
Crossref
Jason D Goldman. (2021) Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic. Clinical Infectious Diseases 72:11, pages e844-e847.
Crossref
Kristin M. D'Silva & Zachary S. Wallace. (2021) COVID-19 and rheumatoid arthritis. Current Opinion in Rheumatology 33:3, pages 255-261.
Crossref
Kristin M. D’Silva & Zachary S. Wallace. (2021) COVID-19 and Disease-Modifying Anti-rheumatic Drugs. Current Rheumatology Reports 23:5.
Crossref
Craig M. CoopersmithMassimo AntonelliSeth R. BauerClifford S. DeutschmanLaura E. EvansRicard FerrerJudith HellmanSameer JogJozef KeseciogluNiranjan KissoonIgnacio Martin-LoechesMark E. NunnallyHallie C. PrescottAndrew RhodesDaniel TalmorPierre TissieresDaniel De Backer. (2021) The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness. Critical Care Medicine 49:4, pages 598-622.
Crossref
Émilien Schultz, Jeremy K. Ward, Laëtitia Atlani-Duault, Seth M. Holmes & Julien Mancini. (2021) French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic. International Journal of Environmental Research and Public Health 18:5, pages 2611.
Crossref
Féline P B Kroon, Ted R Mikuls & Robert BM Landewé. (2021) COVID-19 and how evidence of a new disease evolves. Annals of the Rheumatic Diseases 80:3, pages 401-402.
Crossref
Philip C. Robinson, Jinoos Yazdany & Pedro M. Machado. (2021) Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance. Current Opinion in Rheumatology 33:2, pages 111-116.
Crossref
Bugra Han Egeli, Jeffrey A. Sparks, Alfred H.J. Kim & Jean W. Liew. (2021) Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?. Best Practice & Research Clinical Rheumatology 35:1, pages 101658.
Crossref
Durga Prasanna Misra, Armen Yuri Gasparyan, Olena Zimba, Marlen Yessirkepov, Vikas Agarwal & George D. Kitas. (2021) Formulating Hypotheses for Different Study Designs. Journal of Korean Medical Science 36:50.
Crossref
Timothy Caulfield, Tania Bubela, Jonathan Kimmelman & Vardit Ravitsky. (2021) Let’s do better: public representations of COVID-19 science. FACETS 6:1, pages 403-423.
Crossref
Sarah L Mackie, Elisabeth Brouwer, Richard Conway, Kornelis S M van der Geest, Puja Mehta, Susan P Mollan, Lorna Neill, Michael Putman, Philip C Robinson & Sebastian E Sattui. (2021) Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. The Lancet Rheumatology 3:1, pages e71-e82.
Crossref
Sarah Friedrich & Tim Friede. (2020) Causal inference methods for small non-randomized studies: Methods and an application in COVID-19. Contemporary Clinical Trials 99, pages 106213.
Crossref
Giuseppe Patti, Veronica Lio, Ilaria Cavallari, Felice Gragnano, Letizia Riva, Paolo Calabrò, Giuseppe Di Pasquale, Vittorio Pengo & Andrea Rubboli. (2020) Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology. American Journal of Cardiovascular Drugs 20:6, pages 559-570.
Crossref
Nikolas Ruffer, Johannes Knitza & Martin Krusche. (2020) #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic. Rheumatology International 40:12, pages 2031-2037.
Crossref
Tessa R. Englund, Alan C. Kinlaw & Saira Z. Sheikh. (2020) Rise and Fall: Hydroxychloroquine and COVID‐19 Global Trends: Interest, Political Influence, and Potential Implications. ACR Open Rheumatology 2:12, pages 760-766.
Crossref
Alice Mason, Emily Rose & Christopher J Edwards. (2020) Clinical management of Lupus patients during the COVID-19 pandemic. Lupus 29:13, pages 1661-1672.
Crossref
Tobias Mütze & Tim Friede. (2020) Data monitoring committees for clinical trials evaluating treatments of COVID-19. Contemporary Clinical Trials 98, pages 106154.
Crossref
Durga Prasanna Misra, Armen Yuri Gasparyan & Olena Zimba. (2020) Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatology International 40:11, pages 1741-1751.
Crossref
Rafael A Badell-Grau, Jordan Patrick Cuff, Brendan P Kelly, Helen Waller-Evans & Emyr Lloyd-Evans. (2020) Investigating the Prevalence of Reactive Online Searching in the COVID-19 Pandemic: Infoveillance Study. Journal of Medical Internet Research 22:10, pages e19791.
Crossref
Eli S. Rosenberg, David R. Holtgrave & Tomoko Udo. (2020) Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19. International Journal of Infectious Diseases 99, pages 38-39.
Crossref
Wolfgang Preiser & Rika Preiser. (2020) Academic publishing in pandemic times. South African Journal of Science 116:9/10.
Crossref
Hilary Miller-Handley, Keith Luckett & Amit Govil. (2020) Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function. Advances in Chronic Kidney Disease 27:5, pages 434-441.
Crossref
Emily Sirotich. (2020) Putting patients at the centre of COVID-19 research. Nature.
Crossref
Tania Bubela, E. Richard Gold, Vivek Goel, Max Morgan, Karen Mossman, Jason Nickerson, David Patrick & Aled Edwards. (2020) Open drug discovery of anti-virals critical for Canada’s pandemic strategy. FACETS 5:1, pages 1019-1036.
Crossref
Cosima Rughiniş, Lorena Dima & Sorina Vasile. (2020) Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility. American Journal of Therapeutics 27:6, pages e573-e583.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.